Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 142

1.

Efficient renal recruitment of macrophages and T cells in mice lacking the duffy antigen/receptor for chemokines.

Vielhauer V, Allam R, Lindenmeyer MT, Cohen CD, Draganovici D, Mandelbaum J, Eltrich N, Nelson PJ, Anders HJ, Pruenster M, Rot A, Schlöndorff D, Segerer S.

Am J Pathol. 2009 Jul;175(1):119-31. doi: 10.2353/ajpath.2009.080590. Epub 2009 Jun 4.

2.

Chemokine homeostasis vs. chemokine presentation during severe acute lung injury: the other side of the Duffy antigen receptor for chemokines.

Zarbock A, Bishop J, Müller H, Schmolke M, Buschmann K, Van Aken H, Singbartl K.

Am J Physiol Lung Cell Mol Physiol. 2010 Mar;298(3):L462-71. doi: 10.1152/ajplung.00224.2009. Epub 2010 Jan 8.

3.

The Duffy antigen receptor for chemokines in acute renal failure: A facilitator of renal chemokine presentation.

Zarbock A, Schmolke M, Bockhorn SG, Scharte M, Buschmann K, Ley K, Singbartl K.

Crit Care Med. 2007 Sep;35(9):2156-63.

PMID:
17855830
4.

Obstructive nephropathy in the mouse: progressive fibrosis correlates with tubulointerstitial chemokine expression and accumulation of CC chemokine receptor 2- and 5-positive leukocytes.

Vielhauer V, Anders HJ, Mack M, Cihak J, Strutz F, Stangassinger M, Luckow B, Gröne HJ, Schlöndorff D.

J Am Soc Nephrol. 2001 Jun;12(6):1173-87.

5.

Contribution of Duffy antigen to chemokine function.

Rot A.

Cytokine Growth Factor Rev. 2005 Dec;16(6):687-94. Epub 2005 Jul 27. Review.

PMID:
16054417
6.

CCR5 deficiency aggravates crescentic glomerulonephritis in mice.

Turner JE, Paust HJ, Steinmetz OM, Peters A, Meyer-Schwesinger C, Heymann F, Helmchen U, Fehr S, Horuk R, Wenzel U, Kurts C, Mittrücker HW, Stahl RA, Panzer U.

J Immunol. 2008 Nov 1;181(9):6546-56.

7.

Duffy antigen/receptor for chemokines (DARC) attenuates angiogenesis by causing senescence in endothelial cells.

Xu L, Ashkenazi A, Chaudhuri A.

Angiogenesis. 2007;10(4):307-18. Epub 2007 Oct 23.

PMID:
17955335
8.

The Duffy antigen receptor for chemokines is up-regulated during acute renal transplant rejection and crescentic glomerulonephritis.

Segerer S, Regele H, MacK M, Kain R, Cartron JP, Colin Y, Kerjaschki D, Schlöndorff D.

Kidney Int. 2000 Oct;58(4):1546-56.

9.

Sequence, evolution and ligand binding properties of mammalian Duffy antigen/receptor for chemokines.

Tournamille C, Blancher A, Le Van Kim C, Gane P, Apoil PA, Nakamoto W, Cartron JP, Colin Y.

Immunogenetics. 2004 Jan;55(10):682-94. Epub 2004 Jan 8.

PMID:
14712331
10.

Throwing light on DARC.

Pruenster M, Rot A.

Biochem Soc Trans. 2006 Dec;34(Pt 6):1005-8. Review.

PMID:
17073738
11.

A high endothelial venule-expressing promiscuous chemokine receptor DARC can bind inflammatory, but not lymphoid, chemokines and is dispensable for lymphocyte homing under physiological conditions.

Kashiwazaki M, Tanaka T, Kanda H, Ebisuno Y, Izawa D, Fukuma N, Akimitsu N, Sekimizu K, Monden M, Miyasaka M.

Int Immunol. 2003 Oct;15(10):1219-27.

PMID:
13679391
12.

Exaggerated response to endotoxin in mice lacking the Duffy antigen/receptor for chemokines (DARC).

Dawson TC, Lentsch AB, Wang Z, Cowhig JE, Rot A, Maeda N, Peiper SC.

Blood. 2000 Sep 1;96(5):1681-4.

13.

The Duffy antigen/receptor for chemokines (DARC) regulates prostate tumor growth.

Shen H, Schuster R, Stringer KF, Waltz SE, Lentsch AB.

FASEB J. 2006 Jan;20(1):59-64.

PMID:
16394268
14.

[Duffy antigen receptor for chemokines attenuates breast cancer growth and metastasis: an experiment with nude mice].

Wang J, Ou ZL, Hou YF, Luo JM, Chen Y, Zhou J, Shen ZZ, Ding J, Shao ZM.

Zhonghua Yi Xue Za Zhi. 2005 Aug 3;85(29):2033-7. Chinese.

PMID:
16313795
15.

Chemokine receptor CCR1 but not CCR5 mediates leukocyte recruitment and subsequent renal fibrosis after unilateral ureteral obstruction.

Eis V, Luckow B, Vielhauer V, Siveke JT, Linde Y, Segerer S, Perez De Lema G, Cohen CD, Kretzler M, Mack M, Horuk R, Murphy PM, Gao JL, Hudkins KL, Alpers CE, Gröne HJ, Schlöndorff D, Anders HJ.

J Am Soc Nephrol. 2004 Feb;15(2):337-47.

16.

Late onset of treatment with a chemokine receptor CCR1 antagonist prevents progression of lupus nephritis in MRL-Fas(lpr) mice.

Anders HJ, Belemezova E, Eis V, Segerer S, Vielhauer V, Perez de Lema G, Kretzler M, Cohen CD, Frink M, Horuk R, Hudkins KL, Alpers CE, Mampaso F, Schlöndorff D.

J Am Soc Nephrol. 2004 Jun;15(6):1504-13. Erratum in: J Am Soc Nephrol. 2004 Aug;15(8):following table of contents.

17.

The Duffy antigen receptor for chemokines: structural analysis and expression in the brain.

Horuk R, Martin A, Hesselgesser J, Hadley T, Lu ZH, Wang ZX, Peiper SC.

J Leukoc Biol. 1996 Jan;59(1):29-38. Review.

PMID:
8558064
18.

Impact of erythrocyte Duffy antigen genetic polymorphism on the distribution of GroBeta-T, a novel human CXC chemokine.

Hepburn TW, Tobia LP, Shi W, McIntyre TA, Davis CB.

J Pharm Pharm Sci. 2007;10(4):486-95.

PMID:
18396564
19.

Lymphocytes are dispensable for glomerulonephritis but required for renal interstitial fibrosis in matrix defect-induced Alport renal disease.

Lebleu VS, Sugimoto H, Miller CA, Gattone VH 2nd, Kalluri R.

Lab Invest. 2008 Mar;88(3):284-92. doi: 10.1038/labinvest.3700715. Epub 2008 Jan 7.

20.

Expression of DARC, CXCR3 and CCR5 in giant cell arteritis.

Brühl H, Vielhauer V, Weiss M, Mack M, Schlöndorff D, Segerer S.

Rheumatology (Oxford). 2005 Mar;44(3):309-13. Epub 2004 Nov 30. Erratum in: Rheumatology (Oxford). 2005 Apr;44(4):569.

PMID:
15572394

Supplemental Content

Support Center